Literature DB >> 28345875

Reactive Oxygen Species Synergize To Potently and Selectively Induce Cancer Cell Death.

Hyang Yeon Lee1, Elizabeth I Parkinson1, Carlotta Granchi2, Ilaria Paterni2, Dipak Panigrahy, Pankaj Seth, Filippo Minutolo2, Paul J Hergenrother1.   

Abstract

A distinctive feature of cancer cells is their elevated levels of reactive oxygen species (ROS), a trait that can cause cancer cells to be more sensitive to ROS-inducing agents than normal cells. ROS take several forms, each with different reactivity and downstream consequence. Here we show that simultaneous generation of superoxide and hydrogen peroxide within cancer cells results in significant synergy, potently and selectively causing cancer cell death. In these experiments superoxide is generated using the NAD(P)H quinone oxidoreductase 1 (NQO1) substrate deoxynyboquinone (DNQ), and hydrogen peroxide is generated using the lactate dehydrogenase A (LDH-A) inhibitor NHI-Glc-2. This combination reduces tumor burden and prolongs survival in a mouse model of lung cancer. These data suggest that simultaneous induction of superoxide and hydrogen peroxide can be a powerful and selective anticancer strategy.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28345875      PMCID: PMC5538730          DOI: 10.1021/acschembio.7b00015

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  55 in total

1.  Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species.

Authors:  Alycen P Lundberg; Joshua M Francis; Malgorzata Pajak; Elizabeth I Parkinson; Kathryn L Wycislo; Thomas J Rosol; Megan E Brown; Cheryl A London; Levent Dirikolu; Paul J Hergenrother; Timothy M Fan
Journal:  Invest New Drugs       Date:  2016-12-14       Impact factor: 3.850

2.  Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis.

Authors:  O W Griffith
Journal:  J Biol Chem       Date:  1982-11-25       Impact factor: 5.157

Review 3.  Reactive oxygen species in cell signaling.

Authors:  V J Thannickal; B L Fanburg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-12       Impact factor: 5.464

Review 4.  The interplay between MYC and HIF in cancer.

Authors:  Chi V Dang; Jung-whan Kim; Ping Gao; Jason Yustein
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

5.  The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity.

Authors:  Branka Radic; Cristina Mayor-Ruiz; Georg E Winter; Vincent A Blomen; Claudia Trefzer; Richard K Kandasamy; Kilian V M Huber; Manuela Gridling; Doris Chen; Thorsten Klampfl; Robert Kralovics; Stefan Kubicek; Oscar Fernandez-Capetillo; Thijn R Brummelkamp; Giulio Superti-Furga
Journal:  Nat Chem Biol       Date:  2014-07-27       Impact factor: 16.174

Review 6.  Mitochondrial reactive oxygen species and cancer.

Authors:  Lucas B Sullivan; Navdeep S Chandel
Journal:  Cancer Metab       Date:  2014-11-28

Review 7.  A mitochondrial superoxide theory for oxidative stress diseases and aging.

Authors:  Hiroko P Indo; Hsiu-Chuan Yen; Ikuo Nakanishi; Ken-Ichiro Matsumoto; Masato Tamura; Yumiko Nagano; Hirofumi Matsui; Oleg Gusev; Richard Cornette; Takashi Okuda; Yukiko Minamiyama; Hiroshi Ichikawa; Shigeaki Suenaga; Misato Oki; Tsuyoshi Sato; Toshihiko Ozawa; Daret K St Clair; Hideyuki J Majima
Journal:  J Clin Biochem Nutr       Date:  2014-12-23       Impact factor: 3.114

8.  YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts.

Authors:  Takahito Nakahara; Aya Kita; Kentaro Yamanaka; Masamichi Mori; Nobuaki Amino; Masahiro Takeuchi; Fumiko Tominaga; Shinji Hatakeyama; Isao Kinoyama; Akira Matsuhisa; Masafumi Kudoh; Masao Sasamata
Journal:  Cancer Res       Date:  2007-09-01       Impact factor: 13.312

9.  Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis.

Authors:  M I Koukourakis; A Giatromanolaki; E Sivridis; G Bougioukas; V Didilis; K C Gatter; A L Harris
Journal:  Br J Cancer       Date:  2003-09-01       Impact factor: 7.640

10.  Clinical implications of high NQO1 expression in breast cancers.

Authors:  Yang Yang; Yan Zhang; Qunying Wu; Xuelian Cui; Zhenhua Lin; Shuangping Liu; Liyan Chen
Journal:  J Exp Clin Cancer Res       Date:  2014-02-05
View more
  4 in total

1.  Structure Determination, Functional Characterization, and Biosynthetic Implications of Nybomycin Metabolites from a Mining Reclamation Site-Associated Streptomyces.

Authors:  Xiachang Wang; Sherif I Elshahawi; Larissa V Ponomareva; Qing Ye; Yang Liu; Gregory C Copley; James C Hower; Bruce E Hatcher; Madan K Kharel; Steven G Van Lanen; Qing-Bai She; S Randal Voss; Jon S Thorson; Khaled A Shaaban
Journal:  J Nat Prod       Date:  2019-12-13       Impact factor: 4.050

2.  Coupling of cell fate selection model enhances DNA damage response and may underlie BE phenomenon.

Authors:  Gökhan Demirkıran; Güleser Kalaycı Demir; Cüneyt Güzeliş
Journal:  IET Syst Biol       Date:  2020-04       Impact factor: 1.615

3.  Diverse compounds from pleuromutilin lead to a thioredoxin inhibitor and inducer of ferroptosis.

Authors:  Evijola Llabani; Robert W Hicklin; Hyang Yeon Lee; Stephen E Motika; Lisa A Crawford; Eranthie Weerapana; Paul J Hergenrother
Journal:  Nat Chem       Date:  2019-05-13       Impact factor: 24.427

Review 4.  The interplay of reactive oxygen species and the epidermal growth factor receptor in tumor progression and drug resistance.

Authors:  Meng-Shih Weng; Jer-Hwa Chang; Wen-Yueh Hung; Yi-Chieh Yang; Ming-Hsien Chien
Journal:  J Exp Clin Cancer Res       Date:  2018-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.